Skip to main content
3SBio Inc. logo

3SBio Inc. — Investor Relations & Filings

Ticker · 1530 ISIN · KYG8875G1029 LEI · 529900P0TQC1E9Y7FN31 HKEX Manufacturing
Open in API
Filings indexed 1,495 across all filing types
Latest filing 2026-06-03 Proxy Solicitation & In…
Country KY Cayman Islands
Listing HKEX 1530

About 3SBio Inc.

http://www.3sbio.com

3SBio Inc. is a biopharmaceutical enterprise specializing in the integrated research, development, production, and commercialization of innovative biopharmaceutical products. The company operates as a biotechnology firm, focusing on the discovery, development, manufacture, and marketing of biologics, with a particular emphasis on mammalian cell-based biopharmaceuticals. 3SBio addresses critical medical needs by providing an extensive range of products and services to markets both domestically and internationally.

Recent filings

Filing Released Lang Actions
PROXY FORM FOR ANNUAL GENERAL MEETING TO BE HELD ON THURSDAY, 25 JUNE 2026 AT 10:00 A.M.
Proxy Solicitation & Information Statement Classification · 96% confidence The document is a proxy form for shareholders to appoint a proxy and vote on AGM resolutions (re-election of directors, dividend declaration, auditor appointment, general mandates, etc.). This is a solicitation of proxies and informational statement for the Annual General Meeting, matching the Proxy Solicitation & Information Statement category.
2026-06-03 English
NOTICE OF THE ANNUAL GENERAL MEETING
Proxy Solicitation & Information Statement Classification · 90% confidence The document is the formal notice of the Annual General Meeting, listing resolutions, voting instructions, proxy appointment details, dividend and share issue mandates. It is sent to shareholders to request votes and provide meeting logistics and agenda. This aligns with “Proxy Solicitation & Information Statement (PSI)” rather than the AGM presentation materials (AGM-R) or a report itself.
2026-06-03 English
GENERAL MANDATES TO ISSUE AND REPURCHASE SHARES, RE-ELECTION OF DIRECTORS, DECLARATION AND PAYMENT OF FINAL DIVIDEND OUT OF THE SHARE PREMIUM ACCOUNT OF THE COMPANY, PROPOSED CHANGE OF AUDITOR AND NOT
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a shareholder circular containing notice of the Annual General Meeting, explanatory statements on resolutions (general mandates to issue and repurchase shares, director re-elections, dividend declaration, auditor change), and proxy form for voting. This is a classic proxy solicitation/information statement rather than the report itself, fitting the Proxy Solicitation & Information Statement category (PSI).
2026-06-03 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2026
Regulatory Filings Classification · 80% confidence The document is a monthly return (Form FF301) filed to the Hong Kong Stock Exchange under Listing Rule Chapter 19B, detailing movements in authorised and issued share capital, share option exercises, and public float confirmations. It is a recurring compliance filing rather than a standalone financial report, earnings release, board change announcement or specific share issue notice. This falls under general regulatory filings for exchange compliance.
2026-06-01 English
PROPOSED CHANGE OF AUDITOR
Regulatory Filings Classification · 85% confidence The document is a regulatory announcement by 3SBio Inc. under HKEx Listing Rule 13.51(4) proposing the change of external auditor from EY to KPMG. It does not contain actual financial statements, earnings data, nor is it an AGM presentation or audit report itself. It is a compliance announcement about a corporate change. There is no dedicated category for auditor changes, so under the fallback ‘Regulatory Filings’ category (RNS) it best fits as a general regulatory announcement.
2026-05-26 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2026
Regulatory Filings Classification · 95% confidence The document is a monthly return filing for an equity issuer listed on the Hong Kong Stock Exchange, detailing movements in share capital, issued shares, treasury shares, and public float sufficiency confirmation. It includes specific data on share options exercised and changes in issued shares for the month ended 30 April 2026. The document is a regulatory submission reporting share capital and share movement information, not a financial report, earnings release, or management discussion. It is not an announcement of a report publication but a regulatory filing itself. Therefore, it fits best under the category of Regulatory Filings (RNS), which is the fallback for miscellaneous regulatory announcements that do not fit other specific categories.
2026-05-06 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.